Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing

J. van Ingen (Nijmegen, Netherlands)

Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Session: New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Session type: Guidelines session
Number: 3242

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van Ingen (Nijmegen, Netherlands). Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing. International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: